Journal Information
Vol. 4. Issue 2.
Pages 217-231 (March - April 1998)
Share
Share
Download PDF
More article options
Vol. 4. Issue 2.
Pages 217-231 (March - April 1998)
Artigo de revisão/Review article
Open Access
Metástases ósseas
Bone metastases. Theoretical review
Visits
5572
Maria De Jesus Valente1, Fernanda Paula1, Agostinho Costa2, Maria José Melo3
1 Interna do Internato Complementar de Pneumologia, Hospital de Pulido Valente. 1750 Lisboa.
2 Assistente Graduado de Pneumologia, Hospital de Pulido Valente. 1750 Lisboa.
3 Chefe de Serviço de Pneumologia, Hospital de Pulido Valente. 1750 Lisboa.
This item has received

Under a Creative Commons license
Article information
RESUMO

Os autores elaboraram uma revisão teórica sobre metástases ósseas, fouado os seguintes aspectos: incidência e distribuçāo; mecanisnaos e patogénese; diagnóstico, tratamento, avaliação da resposta ao tratamento e prognóstico.

REV PORT PNEUMOL 1998; IV (2): 217-231

Palavras chave:
Metástases ósseas
Cancro
ABSTRACT

The autors have drown up a theoretical review on bone metastases, aiming the following issues: incidence and distribution, mechanisms and pathogenesis, diagnosis, treatment, assessment of response to treatment and prognosis.

REV PORT PNEUMOL 1998; IV (2): 217-231

Key-words:
Bone metastases
Cancer
Full text is only aviable in PDF
BIBIOGRAFIA
[1.]
R.D. Rubens.
Nature of metastatic bone disease.
Metastatic Bone Disease, (1994), pp. 12-19
[2.]
B. Krempien.
Morphological findings in bone metastases, tumorosteopathy and antiosteolytic therapy.
(1994), pp. 59-85
[3.]
L. Hyde, C.L. Hyde.
Clinical manifestations of lung cancer.
Chest., 65 (1974), pp. 299-306
[4.]
P. Lamy, D. Anthoine, G. Rebeix.
Ostéoses et myéloses cancéreuses d' origine bronchique (Metastatic of bone and bone marrow in bronchogenic carcinoma).
Rev Tuber., 29 (1965), pp. 401
[5.]
A. Clain.
Secondary malignant disease of bone.
Br. J Cancer, 19 (1965), pp. 15
[6.]
I.J. Diel.
Historial remarks on metastases and metastatic bone disease.
Metastatic Bone Disease, (1994), pp. 1-11
[8.]
M.J. Seibel, I. Lambrinoudaki, A. Zipf.
Biochemical markers of bone metabolism in metastatic bone disease, in: Metastatic Bone Disease.
Fundamental and Clinical Aspects., 109–126 (1994),
[9.]
M. Pecherstorfer, I. Zimmer-Roth, T. Schilling, et al.
The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase and urinary ycalcium excretion in neoplastic bone disease.
J Clin Endocrinol Metab., 80 (1995), pp. 97-103
[10.]
HERBERT FLEICH, Osteolytic tumor bone disease, in Biphosphonatcs in bone disease. From the laboratory to the patient. Parthenon Publishing. Second Edition. 86-109.
[11.]
L.D. Napoli, H. Hansen, H.H. Muggia.
The incidence of osseous involvement in lung cancer. with special reference to the development of osteoblastic changes.
Radiology., 3 (1973), pp. 165-175
[12.]
H.H. Hansen.
Diagnosis in metastatic sites.
2nd ed., pp. 185-200
[13.]
G.R. Mundy, B.F. Boyce, T. Yoneda.
Mechanisms of osteolytic bone destuction.
Metastatic Bone Disease. Fundamental and Clinical Aspects, (1994), pp. 86-92
[14.]
Serra Maria José.
Terapéutica paliativa e de suporte.
Oncologia Pneumológica, pp. 409-425
[15.]
O.S. Nielsen.
Palliative treatment of bone metastases.
Acta Oncol, 35 (1996), pp. 58-60
[16.]
S.D. Costa, I.J. Diel, E. Solomayer, G. Von Minc­ Kwitz, G. Bastert.
Systemic treatment of bone metastases: Review of literature and retrospective analysis of 718 breast cancer patients.
Metastatic Bone Disease, pp. 133-143
[17.]
G. Neumann, H. Gautier, J.R. Maury, P. Malamud, J. Perron.
La prise en charge médicale du malade cancéreux pendant de traitement.
Encyclopedic Méd. Chir. Paris. France, Canccérologie - 50055A50-10, 32 (1983), pp. 22-25
[18.]
H. Fleisch.
Biphosphonates: mechanisms of action and clinical use in hypercalcemia of malignancy and tumor-induced bone destruction.
pp. 144-176
[19.]
A.T. Porter, L.P. Davis.
Systemic radionuclide therapy of bone metastases with strontium-89.
Oncology (Huntingt), 8 (1994 Feb), pp. 93-96
[20.]
E. Ben-Josef, A.T. Porter.
Radioisotopoes in the treatment of bone metastases.
Ann Med, 29 (1997 Feb), pp. 31-35
[21.]
R.G. Robinson, D.F. Preston, J.A. Spicer, K.G. Baxter.
Radionuclide therapy of intractable bone pain: ennphasis on strontiu-89.
Semin Nucl Med, 22 (1992 Jan), pp. 28-32
[22.]
J.M. De Klark, B.A. Zonnenberg, G.H. Blijham, A.D. Van Het Schip, A. Hoekstra, S.H. Han, J.M. Quirijnem, Van Dijka, P.P. Van Rjjk.
Treatment of metastatic bone pain using the bone seeking radiopharmaceutical Re-186-HEDP.
Anticancer Re, 17 (1997 May), pp. 1773-1777
[23.]
T. Conroy, L. Malissard, D. Dartois, E. Luporsi, J. Stines, C. Chardot.
Histoire naturelle et evolution des metastases osseuses. A propos de 429 observations.
Bull Cancer, 75 (1988), pp. 845-857
[24.]
H.D. Covelli, A.J. Zaloznick, K.M. Shekifka.
Evaluation of bone pain in carcinoma of lung.
JAMA., 244 (1980), pp. 2625-2630
Copyright © 1998. Sociedade Portuguesa de Pneumologia/SPP
Pulmonology
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?